Supply Chain Intelligence

Amneal Pharmaceuticals, Inc. Supply Chain

AMRX supply chain intelligence for Amneal Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

AMRX ·Last updated 2026-09-13 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
21Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Amneal Pharmaceuticals, Inc. (AMRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

29Total relationships
1Distinct source URLs
11High confidence
0.730Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Amneal Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
DIRECT-CUSTOMER-SOLUTIONS-LLC DIRECT-CUSTOMER-SOLUTIONS-LLC 85% the Company entered into a master logistics services agreement with Direct Customer Solutions, LLC
CHRS Coherus Oncology, Inc. 72% Reciprocal relationship from CHRS graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from CHRS graph: plans and pension benefit managers (via a team of National Account Directors…
RDY Dr. Reddy's Laboratories Limited 72% Reciprocal relationship from RDY graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from RDY graph: t typically decline, in some cases significantly. Accordingly, the level of ma…
SPRY ARS Pharmaceuticals, Inc. 72% Reciprocal relationship from SPRY graph: . We believe that NARCAN’s widespread use clearly demonstrates market uptake in response to the advantages of an intranasal product via proven device over inj…
VERA Vera Therapeutics, Inc. 62% Reciprocal relationship from VERA graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from VERA graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from VERA g…

Amneal Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
ALKS Alkermes plc 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
ALKS Alkermes plc 85% Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX graph: pment purchase Property, plant and …
APACE-PACKAGING-LLC APACE-PACKAGING-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
AVTAR-INVESTMENTS-LLC AVTAR-INVESTMENTS-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
AZATECH-PHARMA-LLC AZATECH-PHARMA-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
KANAN-LLC KANAN-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
TRACY-PROPERTIES-LLC TRACY-PROPERTIES-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
CHRS Coherus Oncology, Inc. 72% Reciprocal relationship from CHRS graph: plans and pension benefit managers (via a team of National Account Directors), servicing account specific questions regarding the billing, coding and reimburs…
SPRY ARS Pharmaceuticals, Inc. 72% Reciprocal relationship from SPRY graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from SPRY graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from SPRY g…
ACTAVIS-ELIZABETH-LLC ACTAVIS-ELIZABETH-LLC 62% Business United States Department of Justice Investigations On May 15, 2023, Amneal Pharmaceuticals LLC (“Amneal”) received a Civil Investigative Demand (“CID”) from the Civil Division of the United …
AMNEAL-GROUP AMNEAL-GROUP 62% fer materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to: • risks related to our proposed transaction to acquire membership i…
AMNEAL-PHARMACEUTICALS-LLC AMNEAL-PHARMACEUTICALS-LLC 62% Business United States Department of Justice Investigations On May 15, 2023, Amneal Pharmaceuticals LLC (“Amneal”) received a Civil Investigative Demand (“CID”) from the Civil Division of the United …
AVPROP-LLC AVPROP-LLC 62% Tracy Properties LLC - operating lease Selling, general and administrative $ 53 $ 177 AvPROP, LLC - operating lease Selling, general and administrative $ 35 $ 53 Ellodi Pharmaceuticals, L.P. - securi…
CAMBER-PHARMACEUTICALS-INC CAMBER-PHARMACEUTICALS-INC 62% ern District of New York (the “USAO”) relating to similar topics concerning the Company’s suspicious order monitoring program and its compliance with the Controlled Substances Act. The Company has be…
DIRECT-CUSTOMER-SOLUTIONS-LLC DIRECT-CUSTOMER-SOLUTIONS-LLC 62% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
DIXON-SHANE-LLC DIXON-SHANE-LLC 62% ern District of New York (the “USAO”) relating to similar topics concerning the Company’s suspicious order monitoring program and its compliance with the Controlled Substances Act. The Company has be…
IMPAX-LABORATORIES-LLC IMPAX-LABORATORIES-LLC 62% Business United States Department of Justice Investigations On May 15, 2023, Amneal Pharmaceuticals LLC (“Amneal”) received a Civil Investigative Demand (“CID”) from the Civil Division of the United …
KASHIV-BIOSCIENCES-LLC KASHIV-BIOSCIENCES-LLC 62% fer materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to: • risks related to our proposed transaction to acquire membership i…
TAKEDA-PHARMACEUTICALS-U-S-A-INC TAKEDA-PHARMACEUTICALS-U-S-A-INC 62% ern District of New York (the “USAO”) relating to similar topics concerning the Company’s suspicious order monitoring program and its compliance with the Controlled Substances Act. The Company has be…
TEVA Teva Pharmaceutical Industries Limited 62% Reciprocal relationship from TEVA graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from TEVA graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from TEVA g…
TEVA-PHARMACEUTICALS-USA-INC TEVA-PHARMACEUTICALS-USA-INC 62% Business United States Department of Justice Investigations On May 15, 2023, Amneal Pharmaceuticals LLC (“Amneal”) received a Civil Investigative Demand (“CID”) from the Civil Division of the United …

Amneal Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AMRX-DEBT Debt stack $2.6B 90% Market cache reports total debt of $2.6B.
AMRX-DEBT-7745 Xbrl Convertible 90% xbrl convertible detail from xbrl 2019-12-31.

Amneal Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Amneal Pharmaceuticals, Inc..

Amneal Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
AMRX-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 319 tracked holders.

Amneal Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
TEVJF Teva Pharmaceutical Industries Limited 100.00 2
VERA Vera Therapeutics, Inc. 100.00 1 ['supplier']
SPRY ARS Pharmaceuticals, Inc. 100.00 1 ['customer', 'supplier']
CHRS Coherus Oncology, Inc. 100.00 1 ['customer', 'supplier']
TEVA Teva Pharmaceutical Industries Limited 100.00 1 ['customer']
DERM Journey Medical Corporation 50.00 2
AZN AstraZeneca PLC 50.00 2
CLYM Climb Bio, Inc. 50.00 2
XYF X Financial 50.00 2
ATR AptarGroup, Inc. 50.00 2
CRNT Ceragon Networks Ltd. 50.00 2
CAH Cardinal Health, Inc. 50.00 2
ALVO Alvotech 50.00 2
ACAD ACADIA Pharmaceuticals Inc. 50.00 2
COYA Coya Therapeutics, Inc. 50.00 2
AUPH Aurinia Pharmaceuticals Inc. 50.00 2
REGN Regeneron Pharmaceuticals, Inc. 50.00 2
ORANY ORANGE 50.00 2
GILD Gilead Sciences, Inc. 50.00 2
BAC Bank of America Corporation 50.00 2
Browse supply chain intel →

See the full supply chain map, all relationships, and real-time alerts for Amneal Pharmaceuticals, Inc..

Unlock full AMRX data — View plans →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map
🔐
AMRX
Unlock AMRX Supply Chain Data
Verified relationships include:
DIRECT-CUSTOMER-SOLUTIONS-LLCDIRECT-CUSTOMER-SOLUTIONS-LLCSupplier85%
CHRSCoherus Oncology, Inc.Supplier72%
ALKSAlkermes plcCustomer85%
ALKSAlkermes plcCustomer85%
+25 more relationships locked
Subscribe — View plans →
Already a subscriber? Sign in →